HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 131 | 141 | 92.9% | |
| HF004 | 2020 | 136 | 151 | 90.1% | |
| HF006 | 2021 | 155 | 167 | 92.8% | |
| HF006 | 2022 | 148 | 153 | 96.7% | |
| HF006 | 2023 | 161 | 168 | 95.8% |
